Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Dec 17, 2015- Acquires unique assets that fit well within Perrigo's Rx extended topicals portfolio
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) announced today that it will acquire a portfolio of generic dosage forms and strengths of Retin-A® (tretinoin) from Matawan Pharmaceuticals,...
-
Nov 23, 2015- Expands Perrigo's Rx extended topicals portfolio to include well-established gastrointestinal product and brand
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) announced today that it will acquire Entocort® (budesonide) capsules as well as the authorized generic capsules marketed by Par Pharmaceuticals...
-
Nov 13, 2015
Perrigo Company plc ("Perrigo," "the Company") (NYSE: PRGO; TASE) today responded to the news that holders of a majority of its shares rejected Mylan's hostile tender offer, thereby expressing...
-
Nov 10, 2015
Perrigo Company plc ("Perrigo," "the Company") (NYSE: PRGO; TASE) issued the following response to Mylan's press release. Mylan is resorting to desperate tactics on the eve of its tender offer...
-
Nov 10, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced it has received an AB therapeutic equivalent rating and final U.S. Food and Drug Administration ("FDA") approval for the generic version of...
-
Nov 9, 2015
Perrigo Company plc ("Perrigo," "the Company") (NYSE: PRGO; TASE) today issued the following shareholder letter: November 9, 2015 CORPORATE GOVERNANCE, MYLAN STYLE: A QUESTION OF TRUST Dear...
-
Nov 9, 2015
Perrigo Company plc ("Perrigo," "the Company") (NYSE: PRGO; TASE) today responded to misleading statements regarding Marc Coucke, Perrigo Board member as well as Executive Committee member. In...
-
Nov 4, 2015
Perrigo Company plc (NYSE: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.125 per share, payable on December 15, 2015 to shareholders of record on...
-
Nov 3, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman and CEO Joseph C. Papa will present at the 24th Annual Credit Suisse Healthcare Conference at 1:00 PM MST (3:00 PM EST)...
-
Oct 30, 2015
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) today commented on the presentation given by Mylan N.V. ("Mylan") (NASDAQ: MYL) in connection with the announcement of its third quarter 2015...